Exact Mass: 349.0885

Exact Mass Matches: 349.0885

Found 64 metabolites which its exact mass value is equals to given mass value 349.0885, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

10-Hydroxydihydrosanguinarine

10-Hydroxydihydrosanguinarine

C20H15NO5 (349.095)


A benzophenanthridine alkaloid comprising dihydrosanguinarine carrying a hydroxy substituent at the 10-position.

   

Ulifloxacin

6-fluoro-1-methyl-4-oxo-7-(piperazin-1-yl)-1H,4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid

C16H16FN3O3S (349.0896)


D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D004791 - Enzyme Inhibitors

   

S-(Formylmethyl)glutathione

(2S)-2-amino-4-{[(1R)-1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(2-oxoethyl)sulfanyl]ethyl]-C-hydroxycarbonimidoyl}butanoic acid

C12H19N3O7S (349.0944)


This compound belongs to the family of Peptides. These are compounds containing an amide derived from two or more amino carboxylic acid molecules (the same or different) by formation of a covalent bond from the carbonyl carbon of one to the nitrogen atom of another.

   

Loracarbef

(6R,7S)-7-[(2R)-2-amino-2-phenylacetamido]-3-chloro-8-oxo-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C16H16ClN3O4 (349.0829)


Loracarbef is only found in individuals that have used or taken this drug. It is a carbacephem antibiotic sometimes grouped together with the second-generation cephalosporin antibiotics. It is marketed under the trade name Lorabid.Loracarbef is an oral, synthetic beta-lactam antibiotic of the carbacephem class. Chemically, carbacephems differ from cephalosporin-class antibiotics in the dihydrothiazine ring where a methylene group has been substituted for a sulfur atom. Loracarbef has a spectrum of activity similar to that of the second generation cephalosporins. It is structurally identical to cefaclor except for a sulfur atom that has been replaced by a methylene group. This change gives greater chemical stability in solution and allows storage at room temperature. Loracarbef, like all b-lactams and cephalosporins, inhibits penicillin binding proteins, enzymes that create the cross-linkage of the peptidoglycan polymer. This binding leads to interference with the formation and remodeling of the cell wall structure. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DC - Second-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   
   

S-(Formylmethyl)glutathione

S-(Formylmethyl)glutathione

C12H19N3O7S (349.0944)


   
   

Maybridge3_004424

Maybridge3_004424

C19H15N3O2S (349.0885)


   

8-Methoxyisodecarine

8-Methoxyisodecarine

C20H15NO5 (349.095)


   

1-Methoxy-2-hydroxy-12-methyl[1,3]benzodioxolo[5,6-c]phenanthridin-13(12H)-one

1-Methoxy-2-hydroxy-12-methyl[1,3]benzodioxolo[5,6-c]phenanthridin-13(12H)-one

C20H15NO5 (349.095)


   

sanguinarin

sanguinarin

C20H15NO5 (349.095)


   

3,6-bismethylthio-cyclo(alanyltryptophyl)

3,6-bismethylthio-cyclo(alanyltryptophyl)

C16H19N3O2S2 (349.0919)


   

2-hydroxy-3-methoxy-12-methyl-12h-[1,3]dioxolo [4,5:4,5]benzo[1,2-c]-phenanthridin-13-one

2-hydroxy-3-methoxy-12-methyl-12h-[1,3]dioxolo [4,5:4,5]benzo[1,2-c]-phenanthridin-13-one

C20H15NO5 (349.095)


   

8-Hydroxydihydrosanguinarine

8-Hydroxydihydrosanguinarine

C20H15NO5 (349.095)


   

N,O-diacetylaristololactam A-II

N,O-diacetylaristololactam A-II

C20H15NO5 (349.095)


   

(+)-7-bromotrypargine|7-bromotrypargine

(+)-7-bromotrypargine|7-bromotrypargine

C15H20BrN5 (349.0902)


   

loracarbef

loracarbef

C16H16ClN3O4 (349.0829)


A synthetic "carba" analogue of cefaclor, with carbon replacing sulfur at position 1. Used to treat a wide range of infections caused by both gram-positive and gram-negative bacteria. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DC - Second-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

ETHYL 2-(BENZOYL-3-CHLORO-4-FLUOROANILINO)PROPANOATE

ETHYL 2-(BENZOYL-3-CHLORO-4-FLUOROANILINO)PROPANOATE

C18H17ClFNO3 (349.0881)


   

Thiazolidine, 3-[(4-methoxyphenyl)sulfonyl]-2-(4-methylphenyl)- (9CI)

Thiazolidine, 3-[(4-methoxyphenyl)sulfonyl]-2-(4-methylphenyl)- (9CI)

C17H19NO3S2 (349.0806)


   

2-DEOXYADENOSINE-5-MONOPHOSPHORIC ACI&

2-DEOXYADENOSINE-5-MONOPHOSPHORIC ACI&

C10H16N5O7P (349.0787)


   
   

4,6-Diamidino-2-phenylindole dihydrochloride

4,6-Diamidino-2-phenylindole dihydrochloride

C16H17Cl2N5 (349.0861)


   

S-Acetylglutathione

γ-Glutamyl-S-acetylcysteinylglycine

C12H19N3O7S (349.0944)


   

METHYL 1-(4-CYANO-PHENYL)-5-(4-METHYLSULFANYL-PHENYL)-1H-PYRAZOLE-3-CARBOXYLATE

METHYL 1-(4-CYANO-PHENYL)-5-(4-METHYLSULFANYL-PHENYL)-1H-PYRAZOLE-3-CARBOXYLATE

C19H15N3O2S (349.0885)


   

(S)-2-BENZYL-3-(BENZYLOXY)-3-OXOPROPANE-1-SULFONIC ACID

(S)-2-BENZYL-3-(BENZYLOXY)-3-OXOPROPANE-1-SULFONIC ACID

C17H19NO5S (349.0984)


   

3-ethyl-2-methylbenzothiazolium p-toluenesulfonate

3-ethyl-2-methylbenzothiazolium p-toluenesulfonate

C17H19NO3S2 (349.0806)


   
   

Dimethachlor Metabolite SYN 528702 sodium salt

Dimethachlor Metabolite SYN 528702 sodium salt

C15H20NNaO5S (349.096)


   

3-(4-Ethoxy-3-methoxy-phenyl)-3-[(thiophene-2-carbonyl)-amino]-propionic acid

3-(4-Ethoxy-3-methoxy-phenyl)-3-[(thiophene-2-carbonyl)-amino]-propionic acid

C17H19NO5S (349.0984)


   

1-(4-Propylphenyl)-2,5-di(2-thienyl)-1H-pyrrole

1-(4-Propylphenyl)-2,5-di(2-thienyl)-1H-pyrrole

C21H19NS2 (349.0959)


   

4-[4-(BENZYLOXY)PHENYL]-5-(2-FURYL)-4H-1,2,4-TRIAZOLE-3-THIOL

4-[4-(BENZYLOXY)PHENYL]-5-(2-FURYL)-4H-1,2,4-TRIAZOLE-3-THIOL

C19H15N3O2S (349.0885)


   

2-(4-Dibenzothiophene)carbazole

2-(4-Dibenzothiophene)carbazole

C24H15NS (349.0925)


   

2-(4-benzofuro[3,2-d]pyrimidinylthio)-N-(3-methylphenyl)acetamide

2-(4-benzofuro[3,2-d]pyrimidinylthio)-N-(3-methylphenyl)acetamide

C19H15N3O2S (349.0885)


   

(Z)-butyl 3-(5-benzylidene-4-oxo-2-thioxothiazolidin-3-yl)propanoate

(Z)-butyl 3-(5-benzylidene-4-oxo-2-thioxothiazolidin-3-yl)propanoate

C17H19NO3S2 (349.0806)


   

7-(2-Amino-2-phenyl-acetylamino)-3-chloro-8-oxo-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid

7-(2-Amino-2-phenyl-acetylamino)-3-chloro-8-oxo-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C16H16ClN3O4 (349.0829)


   

Phenoxymethylpenicillin(1-)

Phenoxymethylpenicillin(1-)

C16H17N2O5S- (349.0858)


   

(6R,7S)-7-{[(2R)-2-ammonio-2-phenylacetyl]amino}-3-chloro-8-oxo-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

(6R,7S)-7-{[(2R)-2-ammonio-2-phenylacetyl]amino}-3-chloro-8-oxo-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

C16H16ClN3O4 (349.0829)


   

N-(5-acetyl-2-phenyl-4-sulfanylidene-1H-pyrimidin-6-yl)benzamide

N-(5-acetyl-2-phenyl-4-sulfanylidene-1H-pyrimidin-6-yl)benzamide

C19H15N3O2S (349.0885)


   

Propan-2-yl 2-(thiophene-2-carbonylamino)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate

Propan-2-yl 2-(thiophene-2-carbonylamino)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate

C17H19NO3S2 (349.0806)


   

4-(4-chloro-2-methylphenoxy)-N-[3-(methylthio)phenyl]butanamide

4-(4-chloro-2-methylphenoxy)-N-[3-(methylthio)phenyl]butanamide

C18H20ClNO2S (349.0903)


   

(5E)-1-(2-fluorophenyl)-5-(1H-indol-3-ylmethylidene)-1,3-diazinane-2,4,6-trione

(5E)-1-(2-fluorophenyl)-5-(1H-indol-3-ylmethylidene)-1,3-diazinane-2,4,6-trione

C19H12FN3O3 (349.0863)


   

N-(1-azabicyclo[2.2.2]octan-3-yl)-6-chloro-7-nitro-1H-benzimidazole-4-carboxamide

N-(1-azabicyclo[2.2.2]octan-3-yl)-6-chloro-7-nitro-1H-benzimidazole-4-carboxamide

C15H16ClN5O3 (349.0942)


   

N-(2-furylmethylene)-2-(10H-phenothiazin-10-yl)acetohydrazide

N-(2-furylmethylene)-2-(10H-phenothiazin-10-yl)acetohydrazide

C19H15N3O2S (349.0885)


   

N,N-bis(2-methoxyethyl)-2-thieno[3,2-b][1]benzothiolecarboxamide

N,N-bis(2-methoxyethyl)-2-thieno[3,2-b][1]benzothiolecarboxamide

C17H19NO3S2 (349.0806)


   

N-(1,3-dimethyl-2-oxo-5-benzimidazolyl)-4-fluoro-3-methylbenzenesulfonamide

N-(1,3-dimethyl-2-oxo-5-benzimidazolyl)-4-fluoro-3-methylbenzenesulfonamide

C16H16FN3O3S (349.0896)


   

6-Amino-1-(4-fluorophenyl)-3-methyl-4-thiophen-2-yl-5-pyrazolo[3,4-b]pyridinecarbonitrile

6-Amino-1-(4-fluorophenyl)-3-methyl-4-thiophen-2-yl-5-pyrazolo[3,4-b]pyridinecarbonitrile

C18H12FN5S (349.0797)


   

6-(2-chlorophenyl)-N-(2-furanylmethyl)-N-methyl-4-quinazolinamine

6-(2-chlorophenyl)-N-(2-furanylmethyl)-N-methyl-4-quinazolinamine

C20H16ClN3O (349.0982)


   

2-(4-(Tert-butyl)benzamido)-4-chloro-5-fluorobenzoic acid

2-(4-(Tert-butyl)benzamido)-4-chloro-5-fluorobenzoic acid

C18H17ClFNO3 (349.0881)


   

7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C16H16ClN3O4 (349.0829)


   

(E)-1-N-methyl-1-N-[2-[[2-(methylaminomethyl)-1,3-thiazol-4-yl]methylsulfonyl]ethyl]-2-nitroethene-1,1-diamine

(E)-1-N-methyl-1-N-[2-[[2-(methylaminomethyl)-1,3-thiazol-4-yl]methylsulfonyl]ethyl]-2-nitroethene-1,1-diamine

C11H19N5O4S2 (349.0878)


   

Ulifloxacin

UNII:C38638H76Y

C16H16FN3O3S (349.0896)


D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D004791 - Enzyme Inhibitors

   

loracarbef zwitterion

loracarbef zwitterion

C16H16ClN3O4 (349.0829)


The zwitterionic form of loracarbef.

   

Hydroxydihydrosanguinarine

Hydroxydihydrosanguinarine

C20H15NO5 (349.095)


   

Sirtuin modulator 2

Sirtuin modulator 2

C19H15N3O2S (349.0885)


Sirtuin modulator 2 (Compound 132) is a sirtuin modulator with an ED50 equal or less than 50 μM[1].

   

17,20-dimethoxy-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2(10),3,8,11,14(19),15,17,20-nonaen-18-ol

17,20-dimethoxy-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2(10),3,8,11,14(19),15,17,20-nonaen-18-ol

C20H15NO5 (349.095)


   

2-[(2s)-2-[(1r)-1-carboxyethyl]-4-hydroxy-5,7-dioxo-2h,3h-furo[2,3-f]isoindol-6-yl]propanoic acid

2-[(2s)-2-[(1r)-1-carboxyethyl]-4-hydroxy-5,7-dioxo-2h,3h-furo[2,3-f]isoindol-6-yl]propanoic acid

C16H15NO8 (349.0798)


   

(2s)-2-[(2r)-6-[(1r)-1-carboxyethyl]-4-hydroxy-5,7-dioxo-2h,3h-furo[2,3-f]isoindol-2-yl]propanoic acid

(2s)-2-[(2r)-6-[(1r)-1-carboxyethyl]-4-hydroxy-5,7-dioxo-2h,3h-furo[2,3-f]isoindol-2-yl]propanoic acid

C16H15NO8 (349.0798)


   

2-[6-(1-carboxyethyl)-4-hydroxy-5,7-dioxo-2h,3h-furo[2,3-f]isoindol-2-yl]propanoic acid

2-[6-(1-carboxyethyl)-4-hydroxy-5,7-dioxo-2h,3h-furo[2,3-f]isoindol-2-yl]propanoic acid

C16H15NO8 (349.0798)


   

(23s)-24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2,4(8),9,11,14,16,21-octaen-23-ol

(23s)-24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2,4(8),9,11,14,16,21-octaen-23-ol

C20H15NO5 (349.095)


   

17-hydroxy-16-methoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2(10),3,8,11,14(19),15,17-octaen-20-one

17-hydroxy-16-methoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2(10),3,8,11,14(19),15,17-octaen-20-one

C20H15NO5 (349.095)


   

10-acetyl-15-methoxy-11-oxo-10-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2(7),3,5,8,12,14-heptaen-14-yl acetate

10-acetyl-15-methoxy-11-oxo-10-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2(7),3,5,8,12,14-heptaen-14-yl acetate

C20H15NO5 (349.095)


   

n-{3-[(1r)-7-bromo-1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-yl]propyl}guanidine

n-{3-[(1r)-7-bromo-1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-yl]propyl}guanidine

C15H20BrN5 (349.0902)


   

17-hydroxy-18-methoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2(10),3,8,11,14(19),15,17-octaen-20-one

17-hydroxy-18-methoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2(10),3,8,11,14(19),15,17-octaen-20-one

C20H15NO5 (349.095)


   

24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2,4(8),9,11,14,16,21-octaen-23-ol

24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2,4(8),9,11,14,16,21-octaen-23-ol

C20H15NO5 (349.095)